Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
2033 (USD BILLION) FIGURE 14 GLP-1 AGONISTS MARKET, BY INDICATION, 2025 VS
Research Characteristics: Triple-action peptide analogue targeting GLP-1, GIP, and glucagon receptor pathways Studied for effects on receptor binding, signaling, and endocrine regulation Examined in laboratory research for its role in energy balance and multi-pathway modulation THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only
It directly predicts which compounds will work best for which goals
Retatrutide is the promising, potentially superior option that carries more uncertainty but offers unique advantages for specific use cases
US$ 28.65
US$ 27.78
US$ 26.69
US$ 23.16
